Cell-penetrating peptides as delivery vehicles for biology and medicine, Org. Biomol. Chem, vol.6, pp.2242-2255, 2008. ,
Cytotoxicity, intracellular distribution and uptake of doxorubicin and doxorubicin coupled to cellpenetrating peptides in different cell lines: a comparative study, Biochem. Biophys. Res. Commun, vol.1, pp.391419-391425, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-00587567
Induction of Apoptosis by Cancer Chemotherapy, Experimental Cell Research, vol.256, issue.1, pp.42-49, 2000. ,
DOI : 10.1006/excr.2000.4838
Role of Curcumin in Cancer Therapy, Current Problems in Cancer, vol.31, issue.4, pp.243-305, 2007. ,
DOI : 10.1016/j.currproblcancer.2007.04.001
A JNK-Dependent Pathway Is Required for TNF??-Induced Apoptosis, Cell, vol.115, issue.1, pp.61-70, 2003. ,
DOI : 10.1016/S0092-8674(03)00757-8
Requirement of JNK for Stress- Induced Activation of the Cytochrome c-Mediated Death Pathway, Science, vol.288, issue.5467, pp.870-874, 2000. ,
DOI : 10.1126/science.288.5467.870
Vinblastine-induced Phosphorylation of Bcl-2 and Bcl-XL Is Mediated by JNK and Occurs in Parallel with Inactivation of the Raf-1/MEK/ERK Cascade, Journal of Biological Chemistry, vol.275, issue.39, pp.275-29980, 2000. ,
DOI : 10.1074/jbc.M003776200
The Bax subfamily of Bcl2-related proteins is essential for apoptotic signal transduction by c-jun NH(2)-terminal kinase, Mol. Cell. Biol, issue.13, pp.22-4929, 2002. ,
JNK phosphorylation of bim-related members of the Bcl-2 family induces Bax-dependent apoptosis, Proc. Natl. Acad. Sci. USA, pp.2432-2437, 2003. ,
Conjugation of doxorubicin to cell penetrating peptides sensitizes human breast MDA-MB 231 cancer cells to endogenous TRAIL-induced apoptosis, Apoptosis, vol.180, issue.3, pp.1352-1365, 2009. ,
DOI : 10.1007/s10495-009-0397-8
URL : https://hal.archives-ouvertes.fr/inserm-00515338
Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231, Cancer Letters, vol.285, issue.1, pp.28-38, 2009. ,
DOI : 10.1016/j.canlet.2009.04.044
URL : https://hal.archives-ouvertes.fr/inserm-00410230
Maurocalcine as a Non Toxic Drug Carrier Overcomes Doxorubicin Resistance in the Cancer Cell Line MDA-MB 231, Pharmaceutical Research, vol.106, issue.Pt 4, pp.11095-11103, 2008. ,
DOI : 10.1007/s11095-008-9782-1
URL : https://hal.archives-ouvertes.fr/inserm-00356481
The expanding role of mitochondria in apoptosis, Genes Dev, vol.15, issue.22, pp.2922-2933, 2001. ,
Mitochondrial reactive oxygen species in cell death signaling, Biochimie, vol.84, issue.2-3, pp.131-141, 2002. ,
DOI : 10.1016/S0300-9084(02)01369-X
Cellular thiols and reactive oxygen species in drug-induced apoptosis, J. Pharmacol. Exp. Ther, pp.296-297, 2001. ,
JNK promotes Bax translocation to mitochondria through phosphorylation of, EMBO J, vol.23, pp.14-17, 2004. ,
Anthracycline-Induced Cardiotoxicity, Cardiovascular & Hematological Agents in Medicinal Chemistry, vol.6, issue.4, pp.278-281, 2008. ,
DOI : 10.2174/187152508785909474
Cardiovascular Toxicity Associated With Cancer Treatment, Clinical Journal of Oncology Nursing, vol.12, issue.4, pp.627-638, 2008. ,
DOI : 10.1188/08.CJON.627-638
Signal Transduction by the JNK Group of MAP Kinases, Cell, vol.103, issue.2, pp.239-252, 2000. ,
DOI : 10.1016/S0092-8674(00)00116-1
The c-Jun N-terminal kinase pathway and apoptotic signaling (review)., International Journal of Oncology, vol.16, pp.651-662, 2000. ,
DOI : 10.3892/ijo.16.4.651
Doxorubicin Requires the Sequential Activation of Caspase-2, Protein Kinase C???, and c-Jun NH2-terminal Kinase to Induce Apoptosis, Molecular Biology of the Cell, vol.16, issue.8, pp.3821-3831, 2005. ,
DOI : 10.1091/mbc.E04-10-0862
Translocation of SAPK/JNK to mitochondria and interaction with Bcl-x(L) in response toDNAdamage, J. Biol. Chem, pp.275-322, 2000. ,
JNK-independent Activation of c-Jun during Neuronal Apoptosis Induced by Multiple DNA-damaging Agents, Journal of Biological Chemistry, vol.278, issue.25, pp.278-22357, 2003. ,
DOI : 10.1074/jbc.M300742200
Synergistic cytotoxicity and apoptosis by Apo-2 ligand and Adriamycin against bladder cancer cells, Clin. Cancer Res, vol.5, pp.2605-2612, 1999. ,
Bortezomib and Depsipeptide Sensitize Tumors to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand: A Novel Method to Potentiate Natural Killer Cell Tumor Cytotoxicity, Cancer Research, vol.66, issue.14, pp.66-7317, 2006. ,
DOI : 10.1158/0008-5472.CAN-06-0680